Literature DB >> 18246096

RIC-3: a nicotinic acetylcholine receptor chaperone.

N S Millar1.   

Abstract

RIC-3 is a transmembrane protein which acts as a molecular chaperone of nicotinic acetylcholine receptors (nAChRs). For some nAChR subtypes (such as homomeric alpha7 neuronal nAChRs), RIC-3 is required for efficient receptor folding, assembly and functional expression. In contrast, for other nAChR subtypes (such as heteromeric alpha4beta2 neuronal nAChRs) there have been reports that RIC-3 can both enhance and reduce levels of functional expression. There is also evidence that RIC-3 can modulate maturation of the closely related 5-hydroxytryptamine (5-HT) receptor (5-HT(3)R). As with heteromeric nAChRs, apparently contradictory results have been reported for the influence of RIC-3 on 5-HT(3)R maturation in different expression systems. Recent evidence indicates that these differences in RIC-3 chaperone activity may be influenced by the host cell, suggesting that other proteins may play an important role in modulating the effects of RIC-3 as a chaperone. RIC-3 was originally identified in the nematode Caenorhabditis elegans as the protein encoded by the gene ric-3 (resistance to inhibitors of cholinesterase) and has subsequently been cloned and characterized from mammalian and insect species. This review provides a brief history of RIC-3; from the identification of the ric-3 gene in C. elegans in 1995 to the more recent demonstration of its activity as a nAChR chaperone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18246096      PMCID: PMC2268041          DOI: 10.1038/sj.bjp.0707661

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  70 in total

Review 1.  Heterologous expression of mammalian and insect neuronal nicotinic acetylcholine receptors in cultured cell lines.

Authors:  N S Millar
Journal:  Biochem Soc Trans       Date:  1999-12       Impact factor: 5.407

2.  The 14-3-3 proteins.

Authors:  A Shaw
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

3.  Characterization of the deg-3/des-2 receptor: a nicotinic acetylcholine receptor that mutates to cause neuronal degeneration.

Authors:  L Yassin; B Gillo; T Kahan; S Halevi; M Eshel; M Treinin
Journal:  Mol Cell Neurosci       Date:  2001-03       Impact factor: 4.314

4.  Differences in the fate of neuronal acetylcholine receptor protein expressed in neurons and stably transfected cells.

Authors:  P D Kassner; D K Berg
Journal:  J Neurobiol       Date:  1997-12

5.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

6.  RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.

Authors:  Stuart J Lansdell; Veronica J Gee; Patricia C Harkness; Anne I Doward; Elizabeth R Baker; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2005-08-24       Impact factor: 4.436

7.  Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.

Authors:  M Bencherif; K Fowler; R J Lukas; P M Lippiello
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

8.  A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans.

Authors:  M Treinin; M Chalfie
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

9.  In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.

Authors:  R D Schwartz; K J Kellar
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

10.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  51 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.

Authors:  Toby Collins; Neil S Millar
Journal:  Mol Pharmacol       Date:  2010-05-12       Impact factor: 4.436

3.  Sorting receptor Rer1 controls surface expression of muscle acetylcholine receptors by ER retention of unassembled alpha-subunits.

Authors:  Christina Valkova; Marina Albrizio; Ira V Röder; Michael Schwake; Romeo Betto; Rüdiger Rudolf; Christoph Kaether
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  A tale of ligands big and small: an update on how pentameric ligand-gated ion channels interact with agonists and proteins.

Authors:  Stephan A Pless; Lucia G Sivilotti
Journal:  Curr Opin Physiol       Date:  2019-06-12

Review 5.  Postsynaptic scaffolds for nicotinic receptors on neurons.

Authors:  Robert A Neff; David Gomez-Varela; Catarina C Fernandes; Darwin K Berg
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

6.  Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor.

Authors:  Thomas Boulin; Marc Gielen; Janet E Richmond; Daniel C Williams; Pierre Paoletti; Jean-Louis Bessereau
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

Review 7.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

8.  Myasthenogenicity of the main immunogenic region.

Authors:  Jon Lindstrom; Jie Luo
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

9.  Conformational changes in alpha 7 acetylcholine receptors underlying allosteric modulation by divalent cations.

Authors:  James T McLaughlin; Sean C Barron; Jennifer A See; Robert L Rosenberg
Journal:  BMC Pharmacol       Date:  2009-01-13

10.  Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

Authors:  Cherie E Bond; Martina Zimmermann; Susan A Greenfield
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.